Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 10 | Longs Won 2/10 20% | Profit Factor 0.41 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $2,654.94 |
| Average Win $2,129.33 | Best Trade (Jul 29) $3,504.44 | Sharpe Ratio -144.87 |
| Average Loss -$1,302.35 | Worst Trade (Jul 29) -$5,440.77 | Z-Score -0.79 (57.13%) |
| Commissions $0 | Avg. Trade Length 3w 3d | Expectancy -$616.02 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 72 | 65 | 58 | 50 | 43 | 36 | 29 | 22 | 14 | 7 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
CLLS Cellectis S.A. - ADR | 6,887.05 | $25,000 | $19,559.23 | - | -$5,440.77 | -21.76% | -1.73% |
DRTS Alpha Tau Medical Ltd. | 2,467.92 | $25,000 | $28,504.44 | - | $3,504.44 | 14.02% | -5.405% |
IMNM Immunome Inc. | 1,109.14 | $25,000 | $25,754.21 | - | $754.21 | 3.02% | +2.834% |
STRO Sutro Biopharma, Inc. | 843.74 | $25,000 | $20,021.94 | - | -$4,978.06 | -19.91% | -1.166% |